P2RX4 and Sepsis: Except for the P2X7R, Csóka and his team in a later study found Macrophage P2X4R augment bacterial killing and protect against sepsis, pharmacological targeting of P2X4R with the allosteric activator ivermectin protects against bacterial dissemination and mortality in sepsis (Csóka et al., 2018).